221 related articles for article (PubMed ID: 21274868)
1. Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance.
Kozlitina J; Boerwinkle E; Cohen JC; Hobbs HH
Hepatology; 2011 Feb; 53(2):467-74. PubMed ID: 21274868
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.
Petersen KF; Dufour S; Hariri A; Nelson-Williams C; Foo JN; Zhang XM; Dziura J; Lifton RP; Shulman GI
N Engl J Med; 2010 Mar; 362(12):1082-9. PubMed ID: 20335584
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease.
Hyysalo J; Stojkovic I; Kotronen A; Hakkarainen A; Sevastianova K; Makkonen J; Lundbom N; Rissanen A; Krauss RM; Melander O; Orho-Melander M; Yki-Järvinen H
J Gastroenterol Hepatol; 2012 May; 27(5):951-6. PubMed ID: 22141340
[TBL] [Abstract][Full Text] [Related]
4. Ethnic differences in hepatic steatosis: an insulin resistance paradox?
Guerrero R; Vega GL; Grundy SM; Browning JD
Hepatology; 2009 Mar; 49(3):791-801. PubMed ID: 19105205
[TBL] [Abstract][Full Text] [Related]
5. APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases.
Zhang RN; Zheng RD; Mi YQ; Zhou D; Shen F; Chen GY; Zhu CY; Pan Q; Fan JG
Dig Dis Sci; 2016 Aug; 61(8):2284-2293. PubMed ID: 27059980
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population.
Niu TH; Jiang M; Xin YN; Jiang XJ; Lin ZH; Xuan SY
World J Gastroenterol; 2014 Apr; 20(13):3655-62. PubMed ID: 24707151
[TBL] [Abstract][Full Text] [Related]
7. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
[TBL] [Abstract][Full Text] [Related]
8. Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans.
Sentinelli F; Romeo S; Maglio C; Incani M; Burza MA; Scano F; Coccia F; Cossu E; Leonetti F; Baroni MG
Lipids Health Dis; 2011 Jun; 10():93. PubMed ID: 21663607
[TBL] [Abstract][Full Text] [Related]
9. Analysis of FTO gene variants with obesity and glucose homeostasis measures in the multiethnic Insulin Resistance Atherosclerosis Study cohort.
Wing MR; Ziegler JM; Langefeld CD; Roh BH; Palmer ND; Mayer-Davis EJ; Rewers MJ; Haffner SM; Wagenknecht LE; Bowden DW
Int J Obes (Lond); 2011 Sep; 35(9):1173-82. PubMed ID: 21102551
[TBL] [Abstract][Full Text] [Related]
10. Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content.
Peter A; Kantartzis K; Machicao F; Machann J; Wagner S; Templin S; Königsrainer I; Königsrainer A; Schick F; Fritsche A; Häring HU; Stefan N
Int J Obes (Lond); 2012 Jun; 36(6):774-82. PubMed ID: 21829161
[TBL] [Abstract][Full Text] [Related]
11. Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent.
Palmer ND; Musani SK; Yerges-Armstrong LM; Feitosa MF; Bielak LF; Hernaez R; Kahali B; Carr JJ; Harris TB; Jhun MA; Kardia SL; Langefeld CD; Mosley TH; Norris JM; Smith AV; Taylor HA; Wagenknecht LE; Liu J; Borecki IB; Peyser PA; Speliotes EK
Hepatology; 2013 Sep; 58(3):966-75. PubMed ID: 23564467
[TBL] [Abstract][Full Text] [Related]
12. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population.
Verrijken A; Beckers S; Francque S; Hilden H; Caron S; Zegers D; Ruppert M; Hubens G; Van Marck E; Michielsen P; Staels B; Taskinen MR; Van Hul W; Van Gaal L
Obesity (Silver Spring); 2013 Oct; 21(10):2138-45. PubMed ID: 23512881
[TBL] [Abstract][Full Text] [Related]
13. Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study.
Wagenknecht LE; Palmer ND; Bowden DW; Rotter JI; Norris JM; Ziegler J; Chen YD; Haffner S; Scherzinger A; Langefeld CD
Liver Int; 2011 Mar; 31(3):412-6. PubMed ID: 21281435
[TBL] [Abstract][Full Text] [Related]
14. Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents.
Santoro N; Zhang CK; Zhao H; Pakstis AJ; Kim G; Kursawe R; Dykas DJ; Bale AE; Giannini C; Pierpont B; Shaw MM; Groop L; Caprio S
Hepatology; 2012 Mar; 55(3):781-9. PubMed ID: 22105854
[TBL] [Abstract][Full Text] [Related]
15. Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C.
Zampino R; Coppola N; Cirillo G; Boemio A; Pisaturo M; Marrone A; Macera M; Sagnelli E; Perrone L; Adinolfi LE; Miraglia del Giudice E
J Viral Hepat; 2013 Aug; 20(8):517-23. PubMed ID: 23808989
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance.
Lee HY; Birkenfeld AL; Jornayvaz FR; Jurczak MJ; Kanda S; Popov V; Frederick DW; Zhang D; Guigni B; Bharadwaj KG; Choi CS; Goldberg IJ; Park JH; Petersen KF; Samuel VT; Shulman GI
Hepatology; 2011 Nov; 54(5):1650-60. PubMed ID: 21793029
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance in lean and overweight non-diabetic Caucasian adults: Study of its relationship with liver triglyceride content, waist circumference and BMI.
Gonzalez-Cantero J; Martin-Rodriguez JL; Gonzalez-Cantero A; Arrebola JP; Gonzalez-Calvin JL
PLoS One; 2018; 13(2):e0192663. PubMed ID: 29425212
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein C3 gene polymorphisms in Southern Indian patients with nonalcoholic fatty liver disease.
Puppala J; Bhrugumalla S; Kumar A; Siddapuram SP; Viswa PD; Kondawar M; Akka J; Munshi A
Indian J Gastroenterol; 2014 Nov; 33(6):524-9. PubMed ID: 25319715
[TBL] [Abstract][Full Text] [Related]
19. PNPLA3 rs738409 risk genotype decouples TyG index from HOMA2-IR and intrahepatic lipid content.
Nádasdi Á; Gál V; Masszi T; Somogyi A; Firneisz G
Cardiovasc Diabetol; 2023 Mar; 22(1):64. PubMed ID: 36944955
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population.
Li MR; Zhang SH; Chao K; Liao XH; Yao JY; Chen MH; Zhong BH
World J Gastroenterol; 2014 Oct; 20(38):14010-7. PubMed ID: 25320541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
